Baolingbao BiologyLtd Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Sijue Dai

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	3.7yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	6.6yrs
Gemiddelde ambtstermijn bestuur	3.7yrs

Recente managementupdates

Recent updates

Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues

Nov 05

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Oct 08

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

Sep 30

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Jul 03

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

Jun 07

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

May 06

CEO

Sijue Dai (29 yo)

3.7yrs

Tenure

CN¥1,406,900

Compensatie

Mr. Sijue Dai serves as a Non-Independent Director at Baolingbao Biology Co., Ltd. since March 15, 2021 and serves as its Chairman and has been its General Manager.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Sijue Dai	GM & Chairman	no data	CN¥1.41m	geen gegevens
Yanjun Wang	CFO & Deputy GM	6.6yrs	geen gegevens	geen gegevens
Xia Li	Deputy General Manager	no data	CN¥544.60k	0.0029% CN¥ 75.6k
Feng Liu	Executive Deputy GM & Non-Independent Director	13.8yrs	CN¥894.00k	0.0044% CN¥ 113.4k
Guogang Zhang	Deputy GM & Secretary of the Board of Directors	3.7yrs	CN¥611.70k	0.025% CN¥ 634.2k

6.6yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 002286 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sijue Dai	GM & Chairman	3.7yrs	CN¥1.41m	geen gegevens
Feng Liu	Executive Deputy GM & Non-Independent Director	13.8yrs	CN¥894.00k	0.0044% CN¥ 113.4k
Huaxiao Xiao	Independent Director	less than a year	geen gegevens	geen gegevens
Yongqiang Huang	Independent Director	7.6yrs	CN¥70.00k	0.0027% CN¥ 69.9k
Hongbo Li	Vice Chairman	4.2yrs	CN¥1.02m	0.0039% CN¥ 100.7k
Cuiping Qin	Non-Independent Director	5.8yrs	CN¥985.50k	0.0039% CN¥ 100.7k
Yurun He	Independent Director	3.7yrs	CN¥70.00k	geen gegevens
Xin Chen	Independent Director	3.2yrs	CN¥70.00k	geen gegevens
Bei Xu	Chairman of Board of Supervisors	1.9yrs	geen gegevens	geen gegevens
Qiang Wang	Director	no data	geen gegevens	0.029% CN¥ 751.9k
Xiaolian Zhao	Independent Directors	less than a year	geen gegevens	geen gegevens
Jun Fang	Independent Directors	less than a year	geen gegevens	geen gegevens

3.7yrs

Gemiddelde duur

51.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 002286 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.7 jaar).

Baolingbao BiologyLtd Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

High number of new directors

Baolingbao Biology Co.,Ltd. Approves Directorate Appointments

Baolingbao Biology Co.,Ltd., Annual General Meeting, Feb 28, 2024

High number of new directors

High number of new and inexperienced directors

Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections

Recent updates

Baolingbao BiologyLtd (SZSE:002286) Strong Profits May Be Masking Some Underlying Issues

New minor risk - Earnings quality

Third quarter 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.031 in 3Q 2023)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Shares Climb 36% But Its Business Is Yet to Catch Up

Baolingbao Biology Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 21%

We Like These Underlying Return On Capital Trends At Baolingbao BiologyLtd (SZSE:002286)

New minor risk - Earnings quality

Second quarter 2024 earnings released: EPS: CN¥0.13 (vs CN¥0.041 in 2Q 2023)

Baolingbao Biology Co.,Ltd.'s (SZSE:002286) Business Is Yet to Catch Up With Its Share Price

Investor sentiment improves as stock rises 19%

Baolingbao Biology Co.,Ltd. to Report First Half, 2024 Results on Jul 31, 2024

Returns On Capital At Baolingbao BiologyLtd (SZSE:002286) Have Stalled

High number of new directors

Earnings Troubles May Signal Larger Issues for Baolingbao BiologyLtd (SZSE:002286) Shareholders

Baolingbao Biology Co.,Ltd. Approves Directorate Appointments

First quarter 2024 earnings released: EPS: CN¥0.06 (vs CN¥0.05 in 1Q 2023)

Investor sentiment deteriorates as stock falls 19%

Baolingbao Biology Co.,Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2023, Payable on 08 March 2024

New minor risk - Earnings quality

Baolingbao Biology Co.,Ltd. Proposes Cash Dividend for 2023

Full year 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.36 in FY 2022)

Baolingbao Biology Co.,Ltd., Annual General Meeting, Feb 28, 2024

Investor sentiment deteriorates as stock falls 18%

Baolingbao Biology Co.,Ltd. to Report Fiscal Year 2023 Results on Feb 07, 2024

New minor risk - Earnings quality

Third quarter 2023 earnings released: EPS: CN¥0.031 (vs CN¥0.057 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: CN¥0.041 (vs CN¥0.13 in 2Q 2022)

Investor sentiment improves as stock rises 17%

Baolingbao Biology Co.,Ltd. to Report First Half, 2023 Results on Aug 25, 2023

Baolingbao Biology Co.,Ltd. Announces Implementation of Final Cash Dividend for 2022, Payable on 20 June 2023

Full year 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.55 in FY 2021)

High number of new directors

Third quarter 2022 earnings released: EPS: CN¥0.057 (vs CN¥0.27 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 2Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.13 (vs CN¥0.17 in 2Q 2021)

Baolingbao Biology Co.,Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on June 27, 2022

Baolingbao Biology Co.,Ltd. Announces Final Cash Dividend for the Year 2021

Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2021

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to CN¥17.55

High number of new and inexperienced directors

Price target decreased to CN¥17.55

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.03 in 3Q 2020)

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.079 in 2Q 2020)

Baolingbao Biology Co.,Ltd. Announces Cash Dividend of A Shares for the Year 2020, Payment Date on June 3, 2021

Baolingbao Biology Co.,Ltd. Approves Cash Dividend for 2020

First quarter 2021 earnings released: EPS CN¥0.02 (vs CN¥0.04 in 1Q 2020)

Baolingbao Biology Co.,Ltd. Proposes Final Cash Dividend for the Year 2020

Baolingbao Biology Co.,Ltd. Approves the Board and Management Elections

New 90-day low: CN¥9.17

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day low: CN¥10.52

Market pulls back on stock over the past week

Third quarter earnings released

New 90-day low: CN¥13.71

First half earnings released

New 90-day high - CN¥19.77

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden